Mela Sciences plans reboot with $12M financing

Mela Sciences plans reboot wit $12M financing

New York medical devices maker Mela Sciences (NSDQ:MELA) is looking to re-invent itself around a new strategy to get its optical diagnostics into clinics, using the proceeds from a new financing round to fund the "re-launch" of its flagship MelaFind device.

Mela said it plans to use its newly raised $12.4 million to "re-launch MelaFind focusing on the key dermatologists who treat many of the patients at high risk for melanoma," as well as to fund clinical trials, expand applications for MelaFind and support general corporate activities.

The funding was raised through a private placement of convertible preferred stock, common stock warrants and common stock to institutional investors, the net proceeds from with total about $11.5 million. In conjunction with the offering Mela directors also purchased about $150,000 in restricted common stock, according to a company statement.

Mela Sciences, whose main product is the mobile MelaFind optical diagnostic system for identifying and diagnosing potential melanoma, has been in a transitional phase since the resignation in June 2013 of long-time CEO Joseph Gulfo, followed by the August termination of 25% of the company’s staff following disappointing quarterly results. Mela in September got a de-listing warning from the NASDAQ Stock Market, which warned that the company must get its share’s above $1 to remain listed on the exchange.

Mela in November put a new face in the corner office, with former Johnson & Johnson (NYSE:JNJ) OTC/nutritionals group chairman Rose Crane taking the title of president & CEO and joining the board of directors.

Alongside the new CEO announcement, Mela also posted deepening losses amid an impressive spike in revenue for its 3rd quarter. Losses grew to $7.4 million, or 17¢ per share, on sales of $107,700 during the 3 months ended September 30. That compared with losses of $5.4 million, or 17¢ per share, on sales of $69,100 during the same period last year. Per-share losses were 7¢ deeper than analysts had projected.

MELA shares gained a few points following yesterday’s private placement announcement, with shares up 1.2% today, trading at 70¢ as of about 1 p.m. Mela’s stock has gained about 11.8% since the start of the year.

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply